<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>A strong association between the presence of <z:hpo ids='HP_0003613'>antiphospholipid antibodies</z:hpo> (aPLab) and arterial and <z:hpo ids='HP_0004936'>venous thrombosis</z:hpo> was observed during the past decade </plain></SENT>
<SENT sid="1" pm="."><plain>aPLab represent a <z:hpo ids='HP_0001425'>heterogeneous</z:hpo> group of immunoglobulins that include the <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> <z:chebi fb="3" ids="50249">anticoagulant</z:chebi> (LA), anticardiolipin antibodies (aCL), and antibodies responsible for false-positive test for <z:e sem="disease" ids="C0039128" disease_type="Disease or Syndrome" abbrv="">syphilis</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>aPLab react with negatively charged, rarely with neutral <z:chebi fb="1" ids="16247">phospholipids</z:chebi> and/or <z:chebi fb="0" ids="16247">phospholipid</z:chebi>-binding proteins </plain></SENT>
<SENT sid="3" pm="."><plain>aPLab are associated with <z:e sem="disease" ids="C1096458" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">vascular occlusion</z:e> in <z:hpo ids='HP_0002960'>autoimmune diseases</z:hpo>, e.g. <z:hpo ids='HP_0002725'>systemic lupus erythematosus</z:hpo> (SLE) </plain></SENT>
<SENT sid="4" pm="."><plain>The role of aCL in ocular vascular occlusive disease involving <z:chebi fb="46" ids="15035">retinal</z:chebi> vessels is unclear </plain></SENT>
<SENT sid="5" pm="."><plain>The aim of this study was to determine the relationship between aPLab and occlusive <z:chebi fb="46" ids="15035">retinal</z:chebi> disease </plain></SENT>
<SENT sid="6" pm="."><plain>A relationship between aCL (IgG), LA, and thrombotic <z:chebi fb="46" ids="15035">retinal</z:chebi> events has been detected in SLE patients, but no association between aPLab and other occlusive <z:chebi fb="46" ids="15035">retinal</z:chebi> diseases (central <z:chebi fb="46" ids="15035">retinal</z:chebi> vein <z:mp ids='MP_0005048'>thrombosis</z:mp>, isolated <z:chebi fb="46" ids="15035">retinal</z:chebi> <z:hpo ids='HP_0002633'>vasculitis</z:hpo>, optic nerve <z:hpo ids='HP_0002633'>vasculitis</z:hpo>) </plain></SENT>
<SENT sid="7" pm="."><plain>In our study the incidence of aCL IgG was higher in patients with <z:e sem="disease" ids="C0004943" disease_type="Disease or Syndrome" abbrv="">Behcet disease</z:e> with non-occlusive <z:mp ids='MP_0005048'>thrombosis</z:mp> than in patients with <z:chebi fb="46" ids="15035">retinal</z:chebi> occlusive events or in patients without occlusions or <z:mp ids='MP_0005048'>thrombosis</z:mp> </plain></SENT>
<SENT sid="8" pm="."><plain>It seems that different mechanisms are responsible for these conditions </plain></SENT>
</text></document>